Clinical Trial

Comparison of Conservative and Endovascular Treatment for Spontaneously Isolated Superior Mesenteric Artery Dissection

Recruiting
View on ClinicalTrials.gov →
Summary
Spontaneous isolated superior mesenteric artery dissection(SISMAD) is an increasingly diagnosed disease. However, prospective, multicenter studies that can provide evidence to support clinical decisions are very limited. This study aims to compare the therapeutic efficacy of conservative and endovascular treatment for SISMAD.
Trial Details
NCT Number NCT05342233
Lead Sponsor Xiangya Hospital of Central South University
Collaborators: The First Medical Center of Chinese PLA General Hospital, West China Hospital, Renmin Hospital of Wuhan University, Peking University Shenzhen Hospital, Affiliated Hospital of Chengde Medical University, Second Affiliated Hospital of Nanchang University, Henan Provincial People's Hospital, The Affiliated Hospital of Inner Mongolia Medical University
Conditions Spontaneous Isolated Superior Mesenteric Artery Dissection
Enrollment 200 participants
Start Date 2022-04-30
Primary Completion 2027-04-01 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2022-04-22